Fix low dose venetoclax-azacitidine treatment of unfit acute myeloid leukemia patients.
The prognosis of elderly AML patients had not even been improved by using hypomethylating agents; however, synergistic effect of combining azacitidin with venetoclax had resulted in a remarkable therapeutic advance. Our goal was...
Read More